%0 Journal Article
%T Infusion Rate Escalation Study of Rituximab in Patients with CD20+ B-Cell Lymphomas: A Single Institution Analysis in Japan
%A Masahiro Yokoyama
%A Yasuhito Terui
%A Kengo Takeuchi
%A Eriko Nara
%J ISRN Oncology
%D 2013
%I Hindawi Publishing Corporation
%R 10.1155/2013/863909
%U http://dx.doi.org/10.1155/2013/863909